News
![](/upload/iblock/23d/23d2694e90ca35fd84dba3674731caae.jpg)
Press Center
![](/upload/resize_cache/iblock/49b/140_80_2/49b831269043640a4c7a75f1c4915422.jpg)
22.07.2020
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
More
Topics Petrovax Pharm